FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma.

MLA

Kwitkowski VE, et al. “FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma.” Oncologist, vol. 15, no. 4, Apr. 2010, pp. 428–35. EBSCOhost, https://doi.org/10.1634/theoncologist.2009-0178.

APA

Kwitkowski VE, Prowell TM, Ibrahim A, Farrell AT, Justice R, Mitchell SS, Sridhara R, & Pazdur R. (2010). FDA approval summary: temsirolimus as treatment for advanced renal cell carcinoma. Oncologist, 15(4), 428–435. https://doi.org/10.1634/theoncologist.2009-0178

Chicago

Kwitkowski VE, Prowell TM, Ibrahim A, Farrell AT, Justice R, Mitchell SS, Sridhara R, and Pazdur R. 2010. “FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma.” Oncologist 15 (4): 428–35. doi:10.1634/theoncologist.2009-0178.